CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter net revenue guidance to a range of $115 to $135 million. In addition, the ...
Company Reports Record Quarterly Revenue of $4.8 Million; Net Loss and Loss per Diluted Share of $5.2 Million and $3.11; ...
CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter net revenue guidance to a range of $115 to $135 million. In addition, the ...
Shareholders are advised that the Naspers group (‘the Group’) is finalising its condensed consolidated interim financial statements for the period ended 30 Sept ...
Life Healthcare has identified assets for an optimisation plan and recorded impairments of approximately R210 million in ...
Detailed price information for Crescent Energy Company Cl A (CRGY-N) from The Globe and Mail including charting and trades.
Paramount Skydance reported mixed Q3 results, but shares surged on optimistic management guidance. Click here to find out why PSKY stock is a Buy.
Gyrodyne, LLC (NASDAQ:GYRO) filed a report with the Securities and Exchange Commission on Wednesday, providing a Regulation FD Disclosure related to its 2025 Annual Shareholders Meeting, which was ...
Crane Harbor Acquisition Corp. (Nasdaq: CHAC), a publicly traded special purpose acquisition company (“Crane Harbor”), and Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum ...
Lassila & Tikanoja plc Stock exchange release20 November 2025 at 4:30 p.m The Finnish Financial Supervisory Authority has approved Lassila & Tikanoja's demerger and listing prospectus; The New Lassila ...
Q3 Revenue of $8.8 million ●Q3 Cash Collections of $10.0 million ●Q3 Thyroid test volume up 12% year-over-year to record levels ●Q3 Thyroid revenue of $8.8M; up 22% year-over-year to record ...
Crane Harbor Acquisition (CHAC) and Xanadu Quantum Technologies announced the confidential submission of a draft registration statement on Form ...